InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: Whalatane post# 124

Wednesday, 03/27/2019 7:33:27 PM

Wednesday, March 27, 2019 7:33:27 PM

Post# of 332
Thank you for your response Whalatane. Makes more sense to me now and I agree it could actually be a bullish indicator. Why extend a failed trial? And if they were redoing it, they would probably need to open a new trial profile on clinical trials. gov after having discussions with the FDA, and not just update a failed trial profile.

Having said that, I also agree on this being a high R/R investment and investing only what one can afford to lose will be important. Cheers.